Basak Pinar Y, Gultekin Fatih, Kilinc Ibrahim, Delibas Namik
Department of Dermatology, Suleyman Demirel University Faculty of Medicine, 32100 Isparta, Turkey.
Eur J Dermatol. 2002 Jan-Feb;12(1):53-7.
Acne vulgaris is a common, inflammatory disease of the pilosebaceous duct. Propionibacterium acnes proliferated in sebum, produces chemotactic factors followed by phagocytosis and this process results in the production of reactive oxygen species which contribute to the inflammatory reaction in papulopustular type acne. Benzoyl peroxide (BP) and BP combination with erythromycin (BP/E) are effective topical medications for the treatment of mild and moderate acne vulgaris. In the present study, the effects of BP and BP/E on antioxidant defence enzymes in 40 patients with papulopustular type acne were evaluated. The activities of superoxide dismutase (SOD), glutathione peroxidase (GSH-Px) and catalase (CAT), and also thiobarbituric acid reactive substance (TBARS) levels were determined in peripheral blood leukocytes in all patients, as well as in tissues of a small group of patients before and at the end of 4 weeks of treatment. No difference was detected in leukocyte antioxidant enzyme activities and TBARS levels due to BP treatment. However, SOD, CAT and GSH-Px activities in leukocytes decreased and TBARS levels increased in BP/E-treated patients (p < 0.05). There was no statistically significant difference between pretreatment and posttreatment enzyme activities in tissue samples. The results of this preliminary study may be attributable to in vivo conditions and possible stability problems while compounding the mixture of the BP/E. Influence of the other ingredients of the formulations applied in the study must also be considered.
寻常痤疮是一种常见的毛囊皮脂腺导管炎症性疾病。痤疮丙酸杆菌在皮脂中增殖,产生趋化因子,随后被吞噬,这一过程导致活性氧的产生,而活性氧会引发丘疹脓疱型痤疮的炎症反应。过氧化苯甲酰(BP)以及BP与红霉素的联合用药(BP/E)是治疗轻度和中度寻常痤疮的有效外用药物。在本研究中,评估了BP和BP/E对40例丘疹脓疱型痤疮患者抗氧化防御酶的影响。测定了所有患者外周血白细胞中超氧化物歧化酶(SOD)、谷胱甘肽过氧化物酶(GSH-Px)和过氧化氢酶(CAT)的活性,以及一小部分患者在治疗4周前和结束时组织中的硫代巴比妥酸反应物质(TBARS)水平。BP治疗后白细胞抗氧化酶活性和TBARS水平未检测到差异。然而,BP/E治疗的患者白细胞中SOD、CAT和GSH-Px活性降低,TBARS水平升高(p < 0.05)。组织样本中治疗前和治疗后酶活性之间无统计学显著差异。这项初步研究的结果可能归因于体内条件以及配制BP/E混合物时可能存在的稳定性问题。还必须考虑研究中使用的制剂其他成分的影响。